XBiotech Inc. (XBIT)
NMS – Real Time Price. Currency in USD
2.33
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
2.33
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
2.33
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
2.33
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 39.03 | 6.05 | 10 | |
| Quick ratio | 39.03 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 4M | N/A | N/A | N/A | N/A |
| Gross Profit | 745K | -2M | -2M | -2M | -2M |
| Operating Income | -34M | -38M | -42M | -56M | -48M |
| Net Income | -33M | -25M | -39M | -46M | -40M |
| EBITDA | -32M | -36M | -41M | -54M | -47M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 79.53 | N/A | 60.98 | 7.8 |
| Y/Y | 999 | 49.42 | N/A | -31.62 | 5.5 |
| 3y average | 632.67 | -16.56 | N/A | -39.16 | 3.3 |
| 5y average | 352.33 | -38.75 | N/A | -9.02 | 3.3 |
| Weighted average score | 5.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $115.5M barely cover the upcoming debt maturities $0.0
Total current assets $117.0M exceed Total current liabilities $3.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$9.0M limits the company's ability to reinvest or pay down debt